- Home
- KROS vs WASH Comparison
KROS vs WASH Comparison
Compare KROS & WASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- WASH
- Stock Information
- Founded
- KROS 2015
- WASH 1800
- Country
- KROS United States
- WASH United States
- Employees
- KROS N/A
- WASH N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- WASH Major Banks
- Sector
- KROS Health Care
- WASH Finance
- Exchange
- KROS Nasdaq
- WASH Nasdaq
- Market Cap
- KROS 558.9M
- WASH 542.9M
- IPO Year
- KROS 2020
- WASH N/A
- Fundamental
- Price
- KROS $14.17
- WASH $29.95
- Analyst Decision
- KROS Buy
- WASH Buy
- Analyst Count
- KROS 13
- WASH 4
- Target Price
- KROS $20.63
- WASH $32.25
- AVG Volume (30 Days)
- KROS 601.6K
- WASH 149.6K
- Earning Date
- KROS 08-06-2025
- WASH 07-21-2025
- Dividend Yield
- KROS N/A
- WASH 7.48%
- EPS Growth
- KROS N/A
- WASH N/A
- EPS
- KROS 0.11
- WASH N/A
- Revenue
- KROS $214,713,000.00
- WASH $110,088,000.00
- Revenue This Year
- KROS $5,006.76
- WASH $57.46
- Revenue Next Year
- KROS N/A
- WASH $9.82
- P/E Ratio
- KROS $127.57
- WASH N/A
- Revenue Growth
- KROS 91657.70
- WASH N/A
- 52 Week Low
- KROS $9.12
- WASH $24.95
- 52 Week High
- KROS $72.37
- WASH $40.59
- Technical
- Relative Strength Index (RSI)
- KROS 59.31
- WASH 69.08
- Support Level
- KROS $13.26
- WASH $29.35
- Resistance Level
- KROS $13.77
- WASH $30.15
- Average True Range (ATR)
- KROS 0.37
- WASH 0.65
- MACD
- KROS 0.05
- WASH 0.28
- Stochastic Oscillator
- KROS 92.54
- WASH 94.27
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.